Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21346315rdf:typepubmed:Citationlld:pubmed
pubmed-article:21346315lifeskim:mentionsumls-concept:C0033325lld:lifeskim
pubmed-article:21346315lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:21346315lifeskim:mentionsumls-concept:C1556096lld:lifeskim
pubmed-article:21346315lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:21346315lifeskim:mentionsumls-concept:C0005684lld:lifeskim
pubmed-article:21346315lifeskim:mentionsumls-concept:C0009221lld:lifeskim
pubmed-article:21346315lifeskim:mentionsumls-concept:C0079419lld:lifeskim
pubmed-article:21346315lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:21346315lifeskim:mentionsumls-concept:C0449258lld:lifeskim
pubmed-article:21346315lifeskim:mentionsumls-concept:C0679109lld:lifeskim
pubmed-article:21346315lifeskim:mentionsumls-concept:C0552449lld:lifeskim
pubmed-article:21346315lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:21346315lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:21346315lifeskim:mentionsumls-concept:C0870071lld:lifeskim
pubmed-article:21346315pubmed:issue3lld:pubmed
pubmed-article:21346315pubmed:dateCreated2011-4-19lld:pubmed
pubmed-article:21346315pubmed:abstractTextp53 codon 72 polymorphism has been reported to be associated with bladder cancer incidence, progression and prognosis, but the association is still under debate. A tentative model was constructed to evaluate the association between p53 codon 72 polymorphism and bladder cancer.lld:pubmed
pubmed-article:21346315pubmed:languageenglld:pubmed
pubmed-article:21346315pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21346315pubmed:citationSubsetIMlld:pubmed
pubmed-article:21346315pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21346315pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21346315pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21346315pubmed:statusMEDLINElld:pubmed
pubmed-article:21346315pubmed:issn1423-0399lld:pubmed
pubmed-article:21346315pubmed:authorpubmed-author:HuangChun-Hsi...lld:pubmed
pubmed-article:21346315pubmed:authorpubmed-author:LinHung-YuHYlld:pubmed
pubmed-article:21346315pubmed:authorpubmed-author:For-WeyLungLlld:pubmed
pubmed-article:21346315pubmed:authorpubmed-author:YuTsan-JungTJlld:pubmed
pubmed-article:21346315pubmed:authorpubmed-author:WuWen-JenWJlld:pubmed
pubmed-article:21346315pubmed:authorpubmed-author:YangMing-Chan...lld:pubmed
pubmed-article:21346315pubmed:copyrightInfoCopyright © 2011 S. Karger AG, Basel.lld:pubmed
pubmed-article:21346315pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21346315pubmed:volume86lld:pubmed
pubmed-article:21346315pubmed:ownerNLMlld:pubmed
pubmed-article:21346315pubmed:authorsCompleteYlld:pubmed
pubmed-article:21346315pubmed:pagination355-60lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:meshHeadingpubmed-meshheading:21346315...lld:pubmed
pubmed-article:21346315pubmed:year2011lld:pubmed
pubmed-article:21346315pubmed:articleTitlep53 codon 72 polymorphism was associated with vulnerability, progression, but not prognosis of bladder cancer in a Taiwanese population: an implication of structural equation modeling to manage the risks of bladder cancer.lld:pubmed
pubmed-article:21346315pubmed:affiliationDepartment of Urology, E-DA Hospital/I-SHOU University, Kaohsiung Medical University, Kaohsiung, Taiwan.lld:pubmed
pubmed-article:21346315pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21346315pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:7157entrezgene:pubmedpubmed-article:21346315lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21346315lld:entrezgene